Cargando…
The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases?
Autor principal: | Tanaka, Yoshiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390877/ https://www.ncbi.nlm.nih.gov/pubmed/30806705 http://dx.doi.org/10.1093/rheumatology/key280 |
Ejemplares similares
-
Medical management of thyroid eye disease – A paradigm shift
por: Honavar, Santosh G
Publicado: (2020) -
Screening for rheumatic heart disease: is a paradigm shift required?
por: Hunter, L D, et al.
Publicado: (2017) -
Staghorn calculi: Understanding the paradigm shift in management
por: Desai, Mahesh, et al.
Publicado: (2020) -
A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013) -
Advances in glaucoma surgery: Paradigm shift in management
por: Pathak-Ray, Vanita
Publicado: (2016)